
Overview
Mehmet Kocoglu is an Oncologist and a Hematologist Oncology provider practicing medicine in Baltimore, Maryland.
Dr. Kocoglu is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Dr. Kocoglu is board certified in American Board Of Internal Medicine - Hematology, 2014. He is actively involved in clinical research, co-authoring 52 peer reviewed articles and participating in 2 clinical trials. Dr. Kocoglu is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
22 South Greene Street, Floor 1, Baltimore, MD 21201
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Sidney Kimmel Comprehensive Cancer Center
Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy. Dr. Brodsky is board certified in American Board Of Internal Medicine. Dr. Brodsky is currently accepting new patients.
Sidney Kimmel Comprehensive Cancer Center
Dr. Nina Wagner-Johnston is Professor of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include non-Hodgkin lymphoma, Hodgkin lymphoma, and HIV-related lymphomas. Dr. Wagner-Johnston serves as the Director for the Lymphoma Drug Development Program at the Johns Hopkins University. Dr. Wagner-Johnston received her baccalaureate degree in nursing from Georgetown University in Washington, DC. She earned her MD and completed her residency training at the University of Chicago, Chicago Illinois. She performed a fellowship in Medical Oncology at Johns Hopkins University, Baltimore, Maryland. Dr. Wagner-Johnston joined the Johns Hopkins faculty in 2015. Prior to joining Johns Hopkins, Dr. Wagner-Johnston was an Assistant Professor at Washington University, St. Louis, Missouri. Her research interests include clinical trial and biomarker development for patients with lymphoma. She is additionally involved in palliative/supportive care research and has a particular interest in chemotherapy-induced peripheral neuropathy. Dr. Wagner-Johnston serves as a member on the NCCN Cancer Related Fatigue Guidelines Panel and the ASCO Neuropathy Guidelines Panel. She has served as a journal reviewer for Annals of Oncology, Leukemia and Lymphoma, Blood, and the Journal of Nuclear Medicine. She is a previous recipient of a Young Investigator Award at the Supportive Oncology Conference as well as a Mentoring Program Award through the American Academy of Hospice and Palliative Medicine. She has served on the National Cancer Institute (NCI) Lymphoma Steering Committee Clinical Trials Design Committee and the NCI Symptom Management and Health Related Quality of Life Steering Committee. She is a member of the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the AIDS Malignancies Consortium (AMC), and the Eastern Cancer Oncology Group (ECOG) Lymphoma Committee. Dr. Wagner-Johnston is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Wagner-Johnston is currently accepting new patients.
Sidney Kimmel Comprehensive Cancer Center
Dr. DeZern is a Professor of Oncology and Medicine at The Johns Hopkins University School of Medicine. She is active in the Division of Hematology Malignancies, Leukemia Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Dr. DeZern has expertise in aplastic anemia, myelodysplastic syndromes, paroxysmal nocturnal hemoglobinuria, acute myeloid leukemia, and bone marrow transplantation. Dr. DeZern received her medical degree at The Johns Hopkins University School of Medicine. She completed a residency in internal medicine at Johns Hopkins, followed by fellowships in medical oncology and hematology, as well as obtained a Masters in Clinical Investigations at the Bloomberg School of Public health. Dr. DeZern is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the American Society for Transplantation and Cellular Therapy. Dr. DeZern’s principle research activities consist of designing and conducting clinical trials that test investigational new therapies and approaches in the treatment of bone marrow failure (aplastic anemia and myelodysplastic syndromes). She has specific expertise in the use of alternative donor bone marrow transplantation in patients with severe aplastic anemia and trials of novel therapeutics for patients with myelodysplastic syndromes. Additionally, she has taken a rigorous approach to the study of diagnostics and supportive case (such as transfusion practices) in these patient populations. She is or has been the Principal Investigator for a number of multicenter trials in collaboration with the MDS Clinical Research Consortium, the Eastern Co-operative Oncology Group (ECOG)-ACRIN and now the Bone Marrow Trials Clinical Trials Network (BMTCTN). She is the Study Chair for the multi-site BMTCTN study (CHAMP) investigating the role of haploidentical donor transplantation using post-transplantation cyclophosphamide in patients with relapsed several aplastic anemia. Dr. DeZern is the local PI as well as the Deputy Chair for The National MDS Study, a collaborative natural history study of the NHLBI and the NCI. As a clinical investigator with a focus on translation of novel treatments to the clinic, Dr. DeZern’s goal is to improve outcomes for patients with bone marrow failure at the bedside and in her research environment. Dr. Dezern is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Dezern is board certified in American Board Of Internal Medicine. Dr. Dezern is currently accepting new patients.
Stoler Outpatient Cancer Clinic
Taofeek Owonikoko is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Owonikoko is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Owonikoko is currently accepting new patients.
Skip Viragh Outpatient Cancer Center
Dr. Matthias Holdhoff is a medical oncologist and co-director of the Brain Cancer Disease Group at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He is a professor of oncology, neurology and neurological surgery at Johns Hopkins University School of Medicine. Dr. Holdhoff’s expertise is in primary brain cancers and central nervous system lymphomas. He earned his medical degree from Freie Universität Berlin, received his doctorate degree at Charité University Medicine Berlin. Dr. Holdhoff completed residency training in internal medicine at Johns Hopkins Bayview Medical Center, followed by a fellowship in medical oncology at Johns Hopkins Hospital with research training at the Ludwig Center for Cancer Genetics and Therapeutics (Kinzler-Vogelstein lab). As a clinical investigator in neuro-oncology, his research is focused on novel trials and translational biomarker studies in malignant gliomas and primary central nervous system lymphomas. He has led and contributed to numerous clinical trials, publications and presentations. Dr. Holdhoff serves as the director of the solid tumor inpatient service at the Sidney Kimmel Comprehensive Cancer Center. He is passionately involved in mentoring and teaching of fellows, residents and students. He is the director of the UCNS-certified neuro-oncology fellowship program at Johns Hopkins, and he is a teaching attending physician for the Osler internal medicine residency program. Dr. Holdhoff is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Glioblastoma, and Brain Tumor. Dr. Holdhoff is board certified in American Board Of Internal Medicine. Dr. Holdhoff is currently accepting new patients.
Skip Viragh Outpatient Cancer Center
Dr. Meyer will serve as the lead medical oncologist for adult sarcoma patients, and will focus on building the Adult Sarcoma and Connective Tissue Oncology Program. In collaboration with pediatric oncologist David Loeb, M.D., Ph.D., and orthopaedic surgeon Kristy Weber, M.D., Meyer will bring novel therapies to the clinic for sarcoma patients. Meyer received his bachelors and masters degrees in cell and molecular biology from Stanford University. From there, he joined the Medical Scientist Training Program at Baylor College of Medicine and earned his medical degree followed by a doctorate in immunology. Meyer completed his residency at the University of Maryland and served as chief resident in medicine from 2004-2005. Afterward, he joined our fellowship program in medical oncology and has been working in the laboratory of Jonathan Powell, M.D., Ph.D., on projects relating to the characterization of molecular regulatory pathways involved in T-cell activation and energy. As a third-year fellow, Meyer served as the chief fellow for our Training Programs in Hematology and Medical Oncology and he received a Young Investigator Award from the American Society of Clinical Oncology in 2010. Dr. Meyer is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Fibrosarcoma, Malignant Peripheral Nerve Sheath Tumor, Osteosarcoma, and Salpingo-Oophorectomy. Dr. Meyer is board certified in American Board Of Internal Medicine. Dr. Meyer is currently accepting new patients.
Frequently Asked Questions about Dr. Mehmet H. Kocoglu
How do I make an appointment with Dr. Mehmet H. Kocoglu?
You can book an appointment with Dr. Mehmet H. Kocoglu by calling their office at 410-328-7609. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mehmet H. Kocoglu a top-rated expert for Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mehmet H. Kocoglu is classified as an Elite expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mehmet H. Kocoglu specialize in?
While Dr. Mehmet H. Kocoglu is a Oncology, they have specific expertise in Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), and Smoldering Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Mehmet H. Kocoglu participate in research or clinical trials?
Yes. Dr. Mehmet H. Kocoglu has published 52 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Mehmet H. Kocoglu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mehmet H. Kocoglu accept my insurance?
Dr. Mehmet H. Kocoglu accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-328-7609 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Multiple MyelomaDr. Kocoglu isElite. Learn about Multiple Myeloma.
- Distinguished
- Bone Marrow TransplantDr. Kocoglu isDistinguished. Learn about Bone Marrow Transplant.
- Relapsed Refractory Multiple Myeloma (RRMM)Dr. Kocoglu isDistinguished. Learn about Relapsed Refractory Multiple Myeloma (RRMM).
- Smoldering Multiple MyelomaDr. Kocoglu isDistinguished. Learn about Smoldering Multiple Myeloma.
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Kocoglu isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- B-Cell LymphomaDr. Kocoglu isAdvanced. Learn about B-Cell Lymphoma.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Myelodysplastic Syndrome (MDS)Dr. Kocoglu isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Primary AmyloidosisDr. Kocoglu isAdvanced. Learn about Primary Amyloidosis.
- Schnitzler SyndromeDr. Kocoglu isAdvanced. Learn about Schnitzler Syndrome.
- Waldenstrom MacroglobulinemiaDr. Kocoglu isAdvanced. Learn about Waldenstrom Macroglobulinemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Kocoglu isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Adult T-Cell LeukemiaDr. Kocoglu isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Kocoglu isExperienced. Learn about Agranulocytosis.
- Bone Marrow AspirationDr. Kocoglu isExperienced. Learn about Bone Marrow Aspiration.
- Cardiac AmyloidosisDr. Kocoglu isExperienced. Learn about Cardiac Amyloidosis.
- Cerebral Amyloid AngiopathyDr. Kocoglu isExperienced. Learn about Cerebral Amyloid Angiopathy.
- Childhood Acute Myeloid LeukemiaDr. Kocoglu isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Familial NeutropeniaDr. Kocoglu isExperienced. Learn about Chronic Familial Neutropenia.
- Chronic Myelomonocytic Leukemia (CMML)Dr. Kocoglu isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Classical Hodgkin LymphomaDr. Kocoglu isExperienced. Learn about Classical Hodgkin Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Kocoglu isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Febrile NeutropeniaDr. Kocoglu isExperienced. Learn about Febrile Neutropenia.
- Follicular LymphomaDr. Kocoglu isExperienced. Learn about Follicular Lymphoma.
- Graft Versus Host Disease (GvHD)Dr. Kocoglu isExperienced. Learn about Graft Versus Host Disease (GvHD).
- Hepatic Venoocclusive Disease with Immunodeficiency
- Hereditary Cerebral Amyloid AngiopathyDr. Kocoglu isExperienced. Learn about Hereditary Cerebral Amyloid Angiopathy.
- Hodgkin LymphomaDr. Kocoglu isExperienced. Learn about Hodgkin Lymphoma.
- IgG4-Related DiseaseDr. Kocoglu isExperienced. Learn about IgG4-Related Disease.
- Inflammatory Myofibroblastic TumorDr. Kocoglu isExperienced. Learn about Inflammatory Myofibroblastic Tumor.
- Large-Cell Immunoblastic LymphomaDr. Kocoglu isExperienced. Learn about Large-Cell Immunoblastic Lymphoma.
- LeukemiaDr. Kocoglu isExperienced. Learn about Leukemia.
- Light Chain Deposition Disease (LCDD)Dr. Kocoglu isExperienced. Learn about Light Chain Deposition Disease (LCDD).
- MAGIC SyndromeDr. Kocoglu isExperienced. Learn about MAGIC Syndrome.
- Mantle Cell Lymphoma (MCL)Dr. Kocoglu isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- Non-Hodgkin LymphomaDr. Kocoglu isExperienced. Learn about Non-Hodgkin Lymphoma.
- Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
- PlasmacytomaDr. Kocoglu isExperienced. Learn about Plasmacytoma.
- Primary Localized Cutaneous AmyloidosisDr. Kocoglu isExperienced. Learn about Primary Localized Cutaneous Amyloidosis.
- Pure Red Cell AplasiaDr. Kocoglu isExperienced. Learn about Pure Red Cell Aplasia.
- Secondary Systemic AmyloidosisDr. Kocoglu isExperienced. Learn about Secondary Systemic Amyloidosis.
- Systemic MastocytosisDr. Kocoglu isExperienced. Learn about Systemic Mastocytosis.




